The final, formatted version of the article will be published soon.
REVIEW article
Front. Endocrinol.
Sec. Cancer Endocrinology
Volume 15 - 2024 |
doi: 10.3389/fendo.2024.1457943
This article is part of the Research Topic Metabolic Crosstalk between Cancer Cells and Immune Cells in the Tumor Microenvironment: Cellular and Molecular Insights, and their Therapeutic Implications View all 8 articles
Trace element Zinc metabolism and its relation to tumors
Provisionally accepted- Kunming Children's Hospital, Kunming, China
Zinc is an essential trace element in the human body, playing a crucial role in cellular metabolism.Dysregulation of zinc homeostasis can lead to abnormal cellular metabolism, contributing to diseases and closely related to tumor development. Adequate zinc intake can maintain zinc homeostasis in the body and support normal cellular metabolism. This review discusses the metabolic processes of zinc in the human body and its close relationship with tumorigenesis. It briefly describes zinc absorption, transport, storage, and release, as well as its important role in gene expression, signal transduction, oxidative stress, immune response, and apoptosis. It focuses on the abnormal cellular metabolism caused by excessive or insufficient zinc, the relationship between zinc homeostasis disruption and metabolic syndrome, and the mechanisms involved in tumor development. It analyzes how changes in the expression and activity of zinc transporters may lead to disrupted zinc homeostasis in tumor tissues. It points out that zinc deficiency is associated with various cancers, including prostate cancer, hepatocellular carcinoma, pancreatic cancer, lung cancer, ovarian cancer, esophageal squamous cell carcinoma, and breast cancer. The summary emphasizes that zinc metalloproteins could serve as potential targets for cancer therapy, and regulating the expression and activity of zinc transport proteins may offer new methods and strategies for clinical cancer treatment.
Keywords: Zinc, zinc metabolism, metabolic syndrome, cancer therapy, controversy
Received: 01 Jul 2024; Accepted: 19 Nov 2024.
Copyright: © 2024 Yao, Wang, Xie, Zhanghuang and Yan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Guiping Yao, Kunming Children's Hospital, Kunming, China
Zhiwei Wang, Kunming Children's Hospital, Kunming, China
Rui Xie, Kunming Children's Hospital, Kunming, China
Chenghao Zhanghuang, Kunming Children's Hospital, Kunming, China
Bing Yan, Kunming Children's Hospital, Kunming, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.